IDO1 Expression Increased After Neoadjuvant Therapy Predicts Poor Pathologic Response and Prognosis in Esophageal Squamous Cell Carcinoma

Ruidi Jiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Ge(Zhengzhou University), Xiaoli Zheng(Zhengzhou University), Shuai Song(Sun Yat-sen University), Zhuo Feng(Henan Cancer Hospital), Yanan Sun(Zhengzhou University)
Frontiers in Oncology
July 7, 2020
10.3389/fonc.2020.01099
Cited by 21

Related Papers

Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment
|Biomaterials|2021|151
Long non-coding RNA HOTAIR knockdown enhances radiosensitivity through regulating microRNA-93/ATG12 axis in colorectal cancer
|Cell Death and Disease|2020|109
Clinical outcome of tyrosine kinase inhibitors alone or combined with radiotherapy for brain metastases from epidermal growth factor receptor (EGFR) mutant non small cell lung cancer (NSCLC)
|Oncotarget|2017|46
<p>Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities</p>
|OncoTargets and Therapy|2019|39
Lipid metabolism analysis in esophageal cancer and associated drug discovery
|Journal of Pharmaceutical Analysis|2023|20